Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin

Laboratory Investigation

Volumn 79, Issue 3, 1999, Pages 301-310

  Huang, Steve C ^a   Zhuang, Zhengping ^a   Weil, Robert J ^b   Pack, Svetlana ^a   Wang, Chaoyu ^a   Krutzsch, Henry C ^a   Pham, Thu A ^a   Lubensky, Irina A ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HYBRID PROTEIN; METHIONINE;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HELA CELL; HUMAN; HUMAN CELL; HYPOPHYSIS TUMOR; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TUMOR CELL; TUMOR SUPPRESSOR GENE;

EID: 0032943815     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, and Marx SJ (1997). Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404-407.
2. Cobrinik D, Dowdy SF, Hinds PW, Mittnacht S, and Weinberg RA (1992). The retinoblastoma protein and the regulation of cell cycling. Trends Biochem Sci 17:312-315.
3. Debelenko LV, Zhuang Z, Emmert-Buck MR, Chandrasekharappa SC, Manickam P, Guru SC, Marx SJ, Skarulis MC, Spiegel AM, Collins FS, Jensen R, Liotta LA, and Lubensky IA (1997). Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res 57:2238-2243.
4. Emmert-Buck MR, Lubensky IA, Dong Q, Manickam P, Guru S, Kester MB, Olufemi S-E, Agarwal S, Burns AL, Spiegel AM, Collins FS, Marx SJ, Zhuang Z, Liotta LA, Chandrasekharappa S, and Debelenko LV (1997). Localization of the multiple endocrine neoplasia type 1 (MEN 1) gene based on tumor LOH analysis. Cancer Res 57:1855-1858.
5. Guru SC, Agarwal SK, Manickam P, Olufemi SE, Crabtree JS, Weisemann JM, Kester MB, Kim YS, Wang Y, Emmert-Buck MR, Liotta LA, Spiegel AM, Boguski MS, Roe BA, Collins FS, Marx SJ, Burns L, and Chandrasekharappa SC (1997a). A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus Genome Res 7:725-735.
6. Guru SC, Olufemi SE, Manickam P, Cummings C, Gieser LM, Pike BL, Bittner ML, Jiang Y, Chinault AC, Nowak NJ, Brzozowska A, Crabtree JS, Wang Y, Roe BA, Weisemann JM, Boguski MS, Agarwal SK, Burns AL, Spiegel AM, Marx SJ, Flejter WL, de Jong PJ, Collins FS, and Chandrasekharappa SC (1997b). A 2.8-Mb clone contig of the multiple endocrine neoplasia type 1 (MEN1) region at 11q13. Genomics 42:436-445.
7. Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS, and Chandrasekharappa SC (1998). Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA 95:1630-1634.
8. Heppner C, Kester MB, Agarwal S. Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi S-E, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, and Marx SJ (1997). Somatic mutations of the MEN1 gene in sporadic parathyroid tumors. Nat Genet 16:375-378.
9. Hinds PW and Weinberg RA (1994). Tumor suppressor genes. Curr Opin Genet Dev 4:135-141.
10. Karin M and Hunter T (1995). Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus. Curr Biol 5:747-757.
11. Knudson AG (1993). Antioncogenes and human cancer. Proc Natl Acad Sci USA 90:10914-10921.
12. Larsson C, Skogseid B, Oberg K, Nakamura Y, and Nordenskjold M (1988). Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85-87.
13. Lee S, Chen DY, Humphrey JS, Gnarra JR, Linehan WM, and Klausner RD (1996). Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc Natl Acad Sci USA 93:1770-1775.
14. Lubensky IA, Debelenko LV, Zhuang Z, Emmert-Buck MR, Dong Q, Chandrasekharappa S, Guru SC, Manickam P, Olufemi SE, Marx SJ, Spiegel AM, Collins FS, and Liotta LA (1996). Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res 56:5272-5278.
15. Manickam P, Guru S, Debelenko LV, Agarwal S, Olufemi S-E, Weisemann J, Boguski M, Crabtree J, Roe B, Wang Y, Lubensky IA, Zhuang Z, Kester MB, Burns AL, Spiegel AM, Marx SJ, Liotta LA, Emmert-Buck MR, Collins FS, and Chandrasekharappa S (1997). Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region. Hum Genet 101:102-108.
16. Metz DC, Jensen RT, Bale AE, Skarulis MC, Eastman RC, Nieman L, Northon JA, Friedman E, Larsson C, Amorossi A, Brandi ML, and Marx SJ (1994). In: Bilezekian JP, Levine MA, and Marcus R, editors. The parathyroids. New York: Raven Press, 591-646.
17. Weil RJ, Huang S, Pack S, Vortmeyer AO, Tsokos M, Lubensky IA, Oldfield EH, and Zhuang Z (1998). Pluripotent tumor cells in benign pituitary adenomas associated with multiple endocrine neoplasia, type 1. Cancer Res 58:4715-4720.
18. Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, Wang C, Park W-S, Agarwal SK, Debelenko LV, Kester MB, Guru SC, Manickam P, Olufemi S-E, Yu F, Heppner C, Crabtree JS, Skarulis MC, Venzon DJ, Emmert-Buck MR, Spiegel AM, Chandrasekharappa SC, Collins FS, Burns AL, Marx SJ, Jensen RT, Liotta LA, and Lubensky IA (1997). Somatic mutations of the MEN 1 gene in sporadic gastrinomas and insulinomas. Cancer Res 57:4682-4686.